Myo-InositolTrisPyroPhosphate Treatment Leads to HIF-1α Suppression and Eradication of Early Hepatoma Tumors in Rats-Reference-Cited by-同舟云学术

Myo-InositolTrisPyroPhosphate Treatment Leads to HIF-1α Suppression and Eradication of Early Hepatoma Tumors in Rats

Published:2011-03-02 Issue:5 Volume:12 Page:777-783
ISSN:1439-4227
Container-title:ChemBioChem
language:en
Short-container-title:ChemBioChem

Author:

Aprahamian Marc,Bour Gaétan,Akladios Chérif Y.,Fylaktakidou Konstantina,Greferath Ruth,Soler Luc,Marescaux Jacques,Egly Jean-Marc,Lehn Jean-Marie,Nicolau Claude

Publisher

Wiley

Subject

Organic Chemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cbic.201000619/fullpdf

Reference21 articles.

1. Physiological effects of high-P50 erythrocyte transfusion on piglets

2. Inositol tripyrophosphate: a new membrane permeant allosteric effector of haemoglobin

3. myo-Inositol Trispyrophosphate: A Novel Allosteric Effector of Hemoglobin with High Permeation Selectivity across the Red Blood Cell Plasma Membrane

4. Suppression of hypoxia-induced HIF-1 and of angiogenesis in endothelial cells by myo-inositol trispyrophosphate-treated erythrocytes

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy;Seminars in Cancer Biology;2023-12

2. Cefmetazole sodium as an allosteric effector that regulates the oxygen supply efficiency of adult hemoglobin;Journal of Biomolecular Structure and Dynamics;2023-08-09

3. Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy;Cancers;2023-02-15

4. New potential treatment for cardiovascular disease through modulation of hemoglobin oxygen binding curve: Myo-inositol trispyrophosphate (ITPP), from cancer to cardiovascular disease;Biomedicine & Pharmacotherapy;2022-10

5. The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia;Frontiers in Pharmacology;2022-07-15